FDA Inspection 1096374 — Creative Testing Solutions

Creative Testing Solutions — FEI 1000140241

The FDA completed an inspection of Creative Testing Solutions on Jul 16, 2019 in Charlotte, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 16, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Charlotte, NC (United States)

Citations

IDCFRDescription
15521 CFR 606.160(b)Required records
926221 CFR 610.40(b)One or more approved screening tests

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.